Both in Pharmaceuticals
Cartesian Therapeutics vs ALX Oncology Holdings
Over the past year RNAC returned −11.5% and ALXO returned −6.8%; their daily moves had a correlation of 0.17.
RNAC −11.5% ALXO −6.8%Growth of $1, one year, split-adjusted
| Metric | RNAC | ALXO |
|---|---|---|
| Price | $6.82 | $1.36 |
| Market cap | $206.3M | $188.1M |
| Today | +6.40% | +5.43% |
| 1 month | +1.0% | +22.5% |
| 6 months | −18.2% | −34.9% |
| Year to date | −5.4% | +20.4% |
| 1 year | −16.1% | −13.4% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 139.7× | — |
| Net cash | $94.8M | $128.5M |
| Dividend yield | — | — |
| Volatility (60d) | 50.8% | 93.1% |
| Short % of float | 15.6% | 6.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).